New Therapeutic And Diagnostic Avenues In Breast Cancer

Recently, the FDA approved the first treatment targeting low levels of Human Epidermal Growth Factor Receptor 2 (HER2). A major scientific advancement and great news for many patients with breast cancer. Oncology doctors have a new way to think about treating patients with breast cancer which leads to better patient outcomes This podcast discusses an important Metastatic breast cancer study that was recently published in the New England Journal of Medicine and presented at ASCO - the American Society of Clinical Oncology in June 2022.